Log in

NYSE:TMOThermo Fisher Scientific Competitors & Alternatives

$382.27
+16.38 (+4.48 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$370.01
Now: $382.27
$386.57
50-Day Range
$332.57
MA: $348.62
$365.89
52-Week Range
$250.21
Now: $382.27
$386.57
Volume1.86 million shs
Average Volume1.90 million shs
Market Capitalization$150.98 billion
P/E Ratio41.92
Dividend Yield0.24%
Beta1.04

Competitors

Thermo Fisher Scientific (NYSE:TMO) Vs. ILMN, A, MTD, BIO, WAT, and PKI

Should you be buying TMO stock or one of its competitors? Companies in the sub-industry of "life sciences tools & services" are considered alternatives and competitors to Thermo Fisher Scientific, including Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Waters (WAT), and PerkinElmer (PKI).

Illumina (NASDAQ:ILMN) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Illumina and Thermo Fisher Scientific, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Illumina241102.53
Thermo Fisher Scientific031002.77

Illumina presently has a consensus price target of $335.1176, indicating a potential downside of 11.67%. Thermo Fisher Scientific has a consensus price target of $353.50, indicating a potential downside of 7.53%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Illumina.

Risk & Volatility

Illumina has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Thermo Fisher Scientific has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.

Profitability

This table compares Illumina and Thermo Fisher Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Illumina26.48%21.78%13.70%
Thermo Fisher Scientific14.31%17.25%8.66%

Earnings and Valuation

This table compares Illumina and Thermo Fisher Scientific's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Illumina$3.54 billion15.74$1.00 billion$6.5757.75
Thermo Fisher Scientific$25.54 billion5.91$3.70 billion$12.3530.95

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.9% of Illumina shares are owned by institutional investors. Comparatively, 87.7% of Thermo Fisher Scientific shares are owned by institutional investors. 0.4% of Illumina shares are owned by insiders. Comparatively, 0.4% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Agilent Technologies (NYSE:A) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership.

Dividends

Agilent Technologies pays an annual dividend of $0.72 per share and has a dividend yield of 0.8%. Thermo Fisher Scientific pays an annual dividend of $0.88 per share and has a dividend yield of 0.2%. Agilent Technologies pays out 23.2% of its earnings in the form of a dividend. Thermo Fisher Scientific pays out 7.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has increased its dividend for 4 consecutive years and Thermo Fisher Scientific has increased its dividend for 2 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Volatility and Risk

Agilent Technologies has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500.

Institutional & Insider Ownership

87.7% of Thermo Fisher Scientific shares are held by institutional investors. 0.4% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Agilent Technologies and Thermo Fisher Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Agilent Technologies13.04%20.76%10.72%
Thermo Fisher Scientific14.31%17.25%8.66%

Earnings & Valuation

This table compares Agilent Technologies and Thermo Fisher Scientific's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$5.16 billion5.34$1.07 billion$3.1128.72
Thermo Fisher Scientific$25.54 billion5.91$3.70 billion$12.3530.95

Thermo Fisher Scientific has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Agilent Technologies and Thermo Fisher Scientific, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Agilent Technologies011802.42
Thermo Fisher Scientific031002.77

Agilent Technologies presently has a consensus price target of $83.6875, indicating a potential downside of 6.30%. Thermo Fisher Scientific has a consensus price target of $353.50, indicating a potential downside of 7.53%. Given Agilent Technologies' higher probable upside, equities analysts plainly believe Agilent Technologies is more favorable than Thermo Fisher Scientific.

Summary

Thermo Fisher Scientific beats Agilent Technologies on 11 of the 17 factors compared between the two stocks.

Thermo Fisher Scientific (NYSE:TMO) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

Profitability

This table compares Thermo Fisher Scientific and Mettler-Toledo International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Thermo Fisher Scientific14.31%17.25%8.66%
Mettler-Toledo International18.38%134.62%20.49%

Earnings and Valuation

This table compares Thermo Fisher Scientific and Mettler-Toledo International's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thermo Fisher Scientific$25.54 billion5.91$3.70 billion$12.3530.95
Mettler-Toledo International$3.01 billion6.54$561.11 million$22.7736.16

Thermo Fisher Scientific has higher revenue and earnings than Mettler-Toledo International. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Thermo Fisher Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Thermo Fisher Scientific and Mettler-Toledo International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Thermo Fisher Scientific031002.77
Mettler-Toledo International27001.78

Thermo Fisher Scientific currently has a consensus target price of $353.50, indicating a potential downside of 7.53%. Mettler-Toledo International has a consensus target price of $708.5556, indicating a potential downside of 13.95%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Mettler-Toledo International.

Insider and Institutional Ownership

87.7% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 94.3% of Mettler-Toledo International shares are owned by institutional investors. 0.4% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 3.2% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Mettler-Toledo International beats Thermo Fisher Scientific on 8 of the 14 factors compared between the two stocks.

Thermo Fisher Scientific (NYSE:TMO) and Bio-Rad Laboratories (NYSE:BIO) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.

Risk & Volatility

Thermo Fisher Scientific has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500.

Profitability

This table compares Thermo Fisher Scientific and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Thermo Fisher Scientific14.31%17.25%8.66%
Bio-Rad Laboratories67.81%3.95%2.84%

Valuation and Earnings

This table compares Thermo Fisher Scientific and Bio-Rad Laboratories' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thermo Fisher Scientific$25.54 billion5.91$3.70 billion$12.3530.95
Bio-Rad Laboratories$2.31 billion5.88$1.76 billion$7.0664.92

Thermo Fisher Scientific has higher revenue and earnings than Bio-Rad Laboratories. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Thermo Fisher Scientific and Bio-Rad Laboratories, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Thermo Fisher Scientific031002.77
Bio-Rad Laboratories00313.25

Thermo Fisher Scientific currently has a consensus price target of $353.50, suggesting a potential downside of 7.53%. Bio-Rad Laboratories has a consensus price target of $470.00, suggesting a potential upside of 2.54%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe Bio-Rad Laboratories is more favorable than Thermo Fisher Scientific.

Institutional and Insider Ownership

87.7% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 63.1% of Bio-Rad Laboratories shares are owned by institutional investors. 0.4% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 27.5% of Bio-Rad Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Thermo Fisher Scientific beats Bio-Rad Laboratories on 9 of the 15 factors compared between the two stocks.

Waters (NYSE:WAT) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for Waters and Thermo Fisher Scientific, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Waters54001.44
Thermo Fisher Scientific031002.77

Waters currently has a consensus target price of $176.3750, suggesting a potential downside of 4.33%. Thermo Fisher Scientific has a consensus target price of $353.50, suggesting a potential downside of 7.53%. Given Waters' higher probable upside, equities research analysts plainly believe Waters is more favorable than Thermo Fisher Scientific.

Profitability

This table compares Waters and Thermo Fisher Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Waters22.77%1,937.83%21.46%
Thermo Fisher Scientific14.31%17.25%8.66%

Insider and Institutional Ownership

95.0% of Waters shares are held by institutional investors. Comparatively, 87.7% of Thermo Fisher Scientific shares are held by institutional investors. 1.5% of Waters shares are held by company insiders. Comparatively, 0.4% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Waters and Thermo Fisher Scientific's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$2.41 billion4.74$592.20 million$8.9920.51
Thermo Fisher Scientific$25.54 billion5.91$3.70 billion$12.3530.95

Thermo Fisher Scientific has higher revenue and earnings than Waters. Waters is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Waters has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500.

Summary

Thermo Fisher Scientific beats Waters on 8 of the 14 factors compared between the two stocks.

Thermo Fisher Scientific (NYSE:TMO) and PerkinElmer (NYSE:PKI) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings & Valuation

This table compares Thermo Fisher Scientific and PerkinElmer's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thermo Fisher Scientific$25.54 billion5.91$3.70 billion$12.3530.95
PerkinElmer$2.88 billion3.87$227.56 million$4.1024.41

Thermo Fisher Scientific has higher revenue and earnings than PerkinElmer. PerkinElmer is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Thermo Fisher Scientific and PerkinElmer's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Thermo Fisher Scientific14.31%17.25%8.66%
PerkinElmer7.82%16.52%7.03%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Thermo Fisher Scientific and PerkinElmer, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Thermo Fisher Scientific031002.77
PerkinElmer010502.33

Thermo Fisher Scientific currently has a consensus target price of $353.50, suggesting a potential downside of 7.53%. PerkinElmer has a consensus target price of $83.7333, suggesting a potential downside of 16.34%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, research analysts plainly believe Thermo Fisher Scientific is more favorable than PerkinElmer.

Volatility & Risk

Thermo Fisher Scientific has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, PerkinElmer has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Institutional and Insider Ownership

87.7% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 93.5% of PerkinElmer shares are held by institutional investors. 0.4% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 0.6% of PerkinElmer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Dividends

Thermo Fisher Scientific pays an annual dividend of $0.88 per share and has a dividend yield of 0.2%. PerkinElmer pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Thermo Fisher Scientific pays out 7.1% of its earnings in the form of a dividend. PerkinElmer pays out 6.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Thermo Fisher Scientific has raised its dividend for 2 consecutive years. PerkinElmer is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Thermo Fisher Scientific beats PerkinElmer on 11 of the 17 factors compared between the two stocks.

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Illumina logo
ILMN
Illumina
1.4$379.39+1.7%$54.85 billion$3.54 billion59.75
Agilent Technologies logo
A
Agilent Technologies
1.6$89.31+0.7%$27.87 billion$5.16 billion41.16Decrease in Short Interest
Mettler-Toledo International logo
MTD
Mettler-Toledo International
1.3$823.45+1.1%$19.48 billion$3.01 billion37.21
Bio-Rad Laboratories logo
BIO
Bio-Rad Laboratories
1.5$458.36+0.9%$13.59 billion$2.31 billion8.78
Waters logo
WAT
Waters
1.2$184.36+1.9%$11.37 billion$2.41 billion22.68Decrease in Short Interest
PerkinElmer logo
PKI
PerkinElmer
1.6$100.09+2.1%$10.91 billion$2.88 billion49.55
BIO-TECHNE logo
TECH
BIO-TECHNE
1.7$269.85+0.2%$10.29 billion$714.01 million57.05
Charles River Laboratories Intl. logo
CRL
Charles River Laboratories Intl.
1.4$181.80+2.7%$8.76 billion$2.62 billion36.58Increase in Short Interest
Bruker logo
BRKR
Bruker
1.9$41.85+0.8%$6.40 billion$2.07 billion37.04Decrease in Short Interest
Luminex logo
LMNX
Luminex
1.2$32.84+2.5%$1.50 billion$334.64 million-218.92Insider Selling
Increase in Short Interest
Pacific Biosciences of California logo
PACB
Pacific Biosciences of California
1.6$3.74+3.7%$577.12 million$90.89 million-11.00Analyst Upgrade
Heavy News Reporting
Fluidigm logo
FLDM
Fluidigm
1.6$4.38+2.5%$338.70 million$117.24 million-5.47
Harvard Bioscience logo
HBIO
Harvard Bioscience
1.6$3.63+5.5%$139.32 million$116.18 million-19.10Increase in Short Interest
aTyr Pharma logo
LIFE
aTyr Pharma
2.0$4.25+0.2%$39.84 million$420,000.00-0.93
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.